with Johnson & Johnson, sending its shares higher. In December, the company said it would work with a division of Johnson & Johnson to develop a potential treatment for cancers like lymphoma and leukemia. Janssen Pharmaceutical agreed to pay Pharmacyclics

the typical companies dividend growth investors love, firms like Coca-Cola (KO), Procter & Gamble (PG) and Johnson & Johnson (JNJ). The first two companies fit the Buffett mantra quite well: Coca-Cola has long been known as "Buffett's favorite holding," yet

& Johnson may invest $85 million or more in Salt Lake City-based Coherex Medical Inc., a medical device maker, and possibly purchase the company in about six months. Johnson & Johnson, the New Brunswick, N.J.-based health-care supply company, will buy equity

selected You are following news about Follow the latest news about JNJ NEW BRUNSWICK, N.J., Feb. 9, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 2012 Leerink Swann Global Health Care Conference on Thursday, Feb. 16, at The Waldorf

of a certain scent take you back to a certain place in your memory? Faith: I think my earliest scent memory would be Johnson & Johnson's Baby Powder—it reminds me of my childhood home, being in Mississippi, and growing up. Tim: Fried catfish and gumbo! Growing

“Working with very prestigious companies for many years, such as Ford, Boeing, BMW, Guess, Honda, Airbus, Carrefour, Johnson & Johnson, P&G, Benetton, and GE, to name a few, it became clear to us that we are ready to provide ‘Social Industry 3D Experiences’.

illegal marketing, false claims, hiding serious problems with their drugs and, in one case (Ortho, a subsidiary of Johnson & Johnson), obstruction of justice and eight counts of persuading employees to destroy documents in a federal investigation. Yet toxic

of Johnson & Johnson hip implants recalled by the company were solicited as clients by an Atlanta law firm that improperly used confidential patient data, according to lawyers defending a suit against a J&J distributor. J&J’s DePuy unit recalled its ASR hips

- Watson Pharmaceuticals Inc. said Wednesday it settled a patent lawsuit brought by a unit of Johnson & Johnson over a generic version of the birth control drug Ortho Tri-Cyclen Lo. Watson said it will start selling an authorized generic version of Ortho Tri-Cyclen

In today's edition, Paul tells Matt about his three favorite dividend stocks: Coca-Cola, Johnson & Johnson, and Procter & Gamble. These are household names with long track records of success, and Paul discusses why these companies have what it takes to kee